Discontinued — last reported Q4 '21
This decline may warrant attention — for this metric, higher values are generally preferred.
Positive income indicates operational viability and efficiency, while a loss suggests the segment is in an investment phase or struggling to achieve scale.
This metric measures the profitability of the Helix segment by subtracting operating expenses from its total revenue. It...
Comparable to operating income or EBIT reported for specific business divisions or subsidiaries at peer life science companies.
ilmn_segment_helix_consolidated_loss_income_from_operations| Q2 '21 | Q3 '21 | Q4 '21 | |
|---|---|---|---|
| Value | $0.00 | $0.00 | $0.00 |